Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

JOURNAL ARTICLE published May 2016 in The Lancet

Research funded by NIH/NCI Cancer Center Support (Grant P30 CA008748)

Authors: Jonathan E Rosenberg | Jean Hoffman-Censits | Tom Powles | Michiel S van der Heijden | Arjun V Balar | Andrea Necchi | Nancy Dawson | Peter H O'Donnell | Ani Balmanoukian | Yohann Loriot | Sandy Srinivas | Margitta M Retz | Petros Grivas | Richard W Joseph | Matthew D Galsky | Mark T Fleming | Daniel P Petrylak | Jose Luis Perez-Gracia | Howard A Burris | Daniel Castellano | Christina Canil | Joaquim Bellmunt | Dean Bajorin | Dorothee Nickles | Richard Bourgon | Garrett M Frampton | Na Cui | Sanjeev Mariathasan | Oyewale Abidoye | Gregg D Fine | Robert Dreicer